{
    "name": "elotuzumab",
    "comment": "Rx",
    "other_names": [
        "Empliciti"
    ],
    "classes": [
        "Antineoplastics",
        "Monoclonal Antibody"
    ],
    "source": "https://reference.medscape.com/drug/empliciti-elotuzumab-1000066",
    "pregnancy": {
        "common": [
            "No available data on use in pregnant women to inform a drug associated risk of major birth defects and miscarriage",
            "Therapy is administered in combination with lenalidomide and dexamethasone or pomalidomide and dexamethasone, which can cause embryo-fetal harm and are contraindicated for use in pregnancy; refer to lenalidomide, pomalidomide and dexamethasone prescribing information for additional information; lenalidomide and pomalidomide are only available through REMS program"
        ],
        "specific": [
            {
                "type": "Contraception",
                "description": [
                    "Refer to lenalidomide and pomalidomide labeling for contraception requirements prior to initiating treatment in females of reproductive potential"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "There are no data on presence of drug in human milk, effects on breastfed child, or on milk production; because of potential for serious adverse reactions in breastfed child from elotuzumab",
            "Administered in combination with lenalidomide and dexamethasone or pomalidomide and dexamethasone, advise lactating women not to breastfeed during treatment; refer to lenalidomide, pomalidomide and dexamethasone"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Infusion reactions (eg, fever, chills, and hypertension) reported; bradycardia and hypotension also developed during infusions (see Dosage Modifications)",
                "Infections reported, including opportunistic infections (eg, fungal infections, herpes zoster); monitor patients for development of infections and treat promptly",
                "Second primary malignancies reported, including solid tumors and skin cancers; monitor patients for development of second primary malignancies",
                "Elevations in liver enzymes (AST/ALT >3x ULN, total bilirubin >2x ULN, and alkaline phosphatase <2x ULN) consistent with hepatotoxicity reported; monitor liver enzymes periodically; stop elotuzumab for Grade â‰¥3 elevation of liver enzymes; consider resuming treatment after return to baseline values",
                "Humanized IgG kappa monoclonal antibody can be detected on both serum protein electrophoresis (SPEP) and immunofixation (IFE) assays; may impact the determination of complete response and possibly relapse from complete response in patients with IgG kappa myeloma protein"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Pneumonia",
            "percent": "14"
        },
        {
            "name": "Fatigue",
            "percent": "13"
        },
        {
            "name": "Diarrhea",
            "percent": "5"
        },
        {
            "name": "Peripheral neuropathy",
            "percent": "3.8"
        },
        {
            "name": "Pyrexia",
            "percent": "2.5"
        },
        {
            "name": "Decreased appetite",
            "percent": "1.6"
        },
        {
            "name": "Decreased weight",
            "percent": "1.3"
        },
        {
            "name": "Constipation",
            "percent": "1.3"
        },
        {
            "name": "Lymphopenia",
            "percent": "8"
        },
        {
            "name": "Pneumonia",
            "percent": "10"
        },
        {
            "name": "Hyperglycemia",
            "percent": "8"
        },
        {
            "name": "Bone pain",
            "percent": "3.3"
        },
        {
            "name": "Constipation",
            "percent": "1.7"
        },
        {
            "name": "Cough",
            "percent": null
        },
        {
            "name": "Upper respiratory tract infection",
            "percent": null
        },
        {
            "name": "Pain in extremities",
            "percent": null
        },
        {
            "name": "Headache",
            "percent": null
        }
    ]
}